Metraipolis › archive › dc_e93409891ebf

The Effect of GLP-1 Agonists on Patients with Metabolic-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis — Europe PMC PMID:41599194

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41599194
DOI
10.3390/pharmaceutics18010086
License (as archived)
solo-consultazione
Archived
2026-11-06T22:44:54.920Z
SHA-256 of the archived text
ad812282f5415e0d6c92348af4706b43762f4ea548b263e00b005fd03a083ca3
Stable URL of this page
https://metraipolis.com/documento/dc_e93409891ebf

How to cite

The Effect of GLP-1 Agonists on Patients with Metabolic-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis — Europe PMC PMID:41599194 — Europe PMC (en), https://europepmc.org/article/MED/41599194 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e93409891ebf (Metraipolis archive dc_e93409891ebf, sha256 ad812282f5415e0d6c92348af4706b43762f4ea548b263e00b005fd03a083ca3)
BibTeX
@misc{dce93409891ebf,
  title = {The Effect of GLP-1 Agonists on Patients with Metabolic-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis — Europe PMC PMID:41599194},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41599194},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e93409891ebf; sha256 ad812282f5415e0d6c92348af4706b43762f4ea548b263e00b005fd03a083ca3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41599194. Agents can read the archived copy with the MCP tool read_document.